首页> 外文期刊>Clinical ophthalmology >Extranodal Rosai-Dorfman disease with bilateral orbital involvement: Report of a case treated with systemic steroid alone
【24h】

Extranodal Rosai-Dorfman disease with bilateral orbital involvement: Report of a case treated with systemic steroid alone

机译:伴有双眼眶侵犯的结外罗莎-多夫曼病:单用全身类固醇治疗的病例报告

获取原文
       

摘要

Abstract: We report the case of a 41-year-old female with bilateral orbital Rosai-Dorfman disease (RDD) and the result of corticosteroid therapy. The patient developed a swollen mass of bilateral upper and lower eye-lid over a six-month period. Diagnosis was based on the characteristic histopathologic features. She was treated with oral corticosteroids 60 mg/per day for ten days and the dose of corticostreoid was tapered every week. She is currently being treated with 10 mg/per day for 4 months. In general, the prognosis is good, with experiencing remission following a course of oral corticosteroids. There is no evidence that corticosteroids are beneficial in the treatment of RDD in the literature, but data regarding such treatment are sparse. A more formalized surveillance of these cases would help to define more clearly the natural history of the disease and the effects of various treatment modalities.
机译:摘要:我们报道了一名41岁女性双侧眼眶Rosai-Dorfman病(RDD)的病例以及皮质类固醇激素治疗的结果。该患者在六个月的时间内出现了双侧上睑和下睑的肿胀。诊断基于特征性组织病理学特征。她每天口服60毫克皮质类固醇激素治疗10天,每周皮质类固醇激素剂量逐渐减少。目前,她每天接受10毫克/毫克的治疗,持续4个月。通常,预后良好,口服皮质类固醇疗程后可缓解。文献中没有证据表明皮质类固醇对RDD的治疗有益,但有关这种治疗的数据很少。对这些病例进行更正式的监视将有助于更清楚地定义疾病的自然史以及各种治疗方式的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号